Literature DB >> 29852319

Functional outcomes and return to sports after surgical treatment of insertional Achilles tendinopathy: Surgical approach tailored to the degree of tendon involvement.

Alexandre Hardy1, Romain Rousseau2, Samir-Pierre Issa2, Antoine Gerometta2, Hugues Pascal-Moussellard2, Benjamin Granger3, Frédéric Khiami2.   

Abstract

INTRODUCTION: Insertional Achilles tendinopathy is a generic term that encompasses several types of ailments. While conservative treatment is less effective than for conditions isolated to the tendon body, there is no consensus as to the best type of surgical care. HYPOTHESIS: Surgical treatment for insertional Achilles tendinopathy that is tailored to the severity of the tendon involvement will lead to satisfactory functional outcomes.
MATERIAL AND METHODS: Forty-six patients were included with an average age of 44.1±11.4 years and a mean preoperative AOFAS score of 62.2±11.7. The mean duration of symptoms before the surgery was 33.1±24 months. The inclusion criteria were pain at the tendon insertion and failure of at least 6 months of conservative treatment. Tendon involvement was evaluated preoperatively using MRI and confirmed intraoperatively after debridement. The primary treatment in all patients was resection of the calcaneal abnormality. Depending on the degree of tendon involvement, debridement or detachment/reattachment were also performed. The minimum follow-up was 12 months.
RESULTS: The mean follow-up was 33±13.5 months. None of the patients were lost to follow-up. The mean AOFAS score was 93.7±7.3 at the last follow-up. The ATRS and VISA-A scores were 89.2±4.1 and 89±3.2, respectively. The sports participation level was the same or higher in 71.7% of cases. Increased preoperative passive dorsiflexion was statistically correlated with the degree of tendon involvement.
CONCLUSION: Surgery for insertional Achilles tendinopathy led to good functional outcomes and satisfactory return to sports when the surgical care was tailored to the sdegree of tendon involvement. LEVEL OF EVIDENCE: IV.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Achilles; Ankle; Calcaneal tendon; Haglund disease; Insertional tendinopathy

Mesh:

Year:  2018        PMID: 29852319     DOI: 10.1016/j.otsr.2018.05.003

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  6 in total

1.  Endoscopic resection of enthesopathy via a direct midline transtendinous approach with associated reattachment of the Achilles tendon (endo-REDMTART): a cadaveric feasibility study.

Authors:  P Laumonerie; L Mattesi; Chaynes Patrick; M E Tibbo; D Ancelin
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-08-21

2.  Endoscopic SpeedBridge Procedure for the Treatment for Insertional Achilles Tendinopathy: The Snake Technique.

Authors:  Ronny Lopes; Giovany Padiolleau; Juliette Fradet; Thais Dutra Vieira
Journal:  Arthrosc Tech       Date:  2021-08-17

3.  Transtendinous approach calcaneoplasty versus endoscopic calcaneoplasty for Haglund's disease.

Authors:  Andrea Cusumano; Nicolò Martinelli; Alberto Bianchi; Angelo Bertelli; Alberto Marangon; Valerio Sansone
Journal:  Int Orthop       Date:  2020-08-07       Impact factor: 3.075

4.  Central Tendon-Splitting Approach and Double Row Suturing for the Treatment of Insertional Achilles Tendinopathy.

Authors:  Ze Zhuang; Yang Yang; Kishor Chhantyal; Jianning Chen; Guohui Yuan; Yirong Ni; Dezhao Liu; Dehai Shi
Journal:  Biomed Res Int       Date:  2019-08-21       Impact factor: 3.411

5.  Surgical treatment for insertional Achilles tendinopathy and retrocalcaneal bursitis: more than 1 year of follow-up.

Authors:  Changgui Zhang; Jin Cao; Liu Yang; Xiaojun Duan
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

6.  Do pre-operative radiologic assessment predict postoperative outcomes in patients with insertional Achilles tendinopathy?: a retrospective database study.

Authors:  Sebastian Felix Baumbach; Hubert Hörterer; Sonja Oppelt; Ulrike Szeimies; Hans Polzer; Markus Walther
Journal:  Arch Orthop Trauma Surg       Date:  2021-04-23       Impact factor: 2.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.